Celldex Therapeutics, Inc. — SC 13G Filings
47 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Celldex Therapeutics, Inc. (CLDX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Celldex Therapeutics, Inc. has filed 47 SC 13G documents with the SEC since 2007. To view all SEC filings by Celldex Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
4
4/A
424B1
424B2
424B3
424B5
425
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DEL AM
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | KYNAM CAPITAL MANAGEMENT, LP | 0001085146-24-001357 | Feb 14, 2024 | — |
| SC 13G | SC 13G | 0001580642-24-000979 | Feb 14, 2024 | — |
| SC 13G | — | 0001172661-24-000763 | Feb 13, 2024 | — |
| SC 13G | CELLDEX THERAPEUTICS, INC. | 0000902664-23-005657 | Nov 20, 2023 | — |
| SC 13G | SEC SCHEDULE 13G | 0000846087-23-000092 | Feb 6, 2023 | — |
| SC 13G | SC 13G | 0001140361-22-022594 | Jun 10, 2022 | — |
| SC 13G | SCHEDULE 13G | 0001104659-22-016770 | Feb 9, 2022 | — |
| SC 13G | — | 0000834237-22-007115 | Feb 4, 2022 | — |
| SC 13G | — | 0000315066-21-001801 | Oct 12, 2021 | — |
| SC 13G | COWEN FINANCIAL PRODUCTS LLC | 0001085146-21-001052 | Feb 25, 2021 | — |
| SC 13G | SC 13G | 0001104659-21-023928 | Feb 16, 2021 | — |
| SC 13G | — | 0000935836-20-000571 | Oct 22, 2020 | — |
| SC 13G | CELLDEX THERAPEUTICS, INC. | 0000902664-20-002780 | Jul 24, 2020 | — |
| SC 13G | THE SCHEDULE 13G | 0000921895-20-001867 | Jun 26, 2020 | — |
| SC 13G | — | 0001493152-20-011453 | Jun 19, 2020 | — |
| SC 13G | SC 13G | 0001193125-20-171962 | Jun 18, 2020 | — |
| SC 13G | — | 0001037389-20-000083 | Feb 12, 2020 | — |
| SC 13G | SC 13G | 0001193125-17-037281 | Feb 10, 2017 | — |
| SC 13G | SC 13G | 0001193125-16-789419 | Dec 9, 2016 | — |
| SC 13G | SCHEDULE 13G | 0001445546-16-006494 | Jan 27, 2016 | — |
| SC 13G | — | 0000932471-14-003942 | Feb 12, 2014 | — |
| SC 13G | — | 0000315066-13-003907 | Sep 10, 2013 | — |
| SC 13G | — | 0000899140-13-000293 | Apr 22, 2013 | — |
| SC 13G | SCHEDULE 13G | 0000899140-13-000266 | Apr 5, 2013 | — |
| SC 13G | — | 0001137774-13-000077 | Feb 13, 2013 | — |
| SC 13G | 13G INITIAL ANNUAL FILING - CLDX | 0000053417-13-000020 | Feb 11, 2013 | — |
| SC 13G | — | 0001086364-13-001145 | Jan 30, 2013 | — |
| SC 13G | SCHEDULE 13G | 0000932440-12-000300 | Dec 28, 2012 | — |
| SC 13G | CELLDEX THERAPEUTICS INC. | 0000902664-11-001023 | May 26, 2011 | — |
| SC 13G | — | 0001086364-11-002475 | Feb 3, 2011 | — |
| SC 13G | SCHEDULE 13G | 0000950123-09-009530 | May 27, 2009 | — |
| SC 13G | SC13G | 0000905718-08-000270 | Feb 28, 2008 | — |
| SC 13G | — | 0000898432-08-000055 | Jan 30, 2008 | — |
| SC 13G | SCHEDULE 13G HOLDINGS REPORT | 0001172661-08-000008 | Jan 16, 2008 | — |
| SC 13G | — | 0001012975-06-000154 | Mar 30, 2006 | — |
| SC 13G | — | 0000898432-05-000536 | Jul 7, 2005 | — |
| SC 13G | AVANT IMMUNOTHERAPEUTICS, INC. / SC 13G | 0000902664-03-000883 | Jul 10, 2003 | — |
| SC 13G | SC 13G | 0000908645-02-000031 | Feb 14, 2002 | — |
| SC 13G | SCHEDULE 13G AMENDMENT | 0001047469-02-000066 | Feb 1, 2002 | — |
| SC 13G | SCHEDULE 13G | 0001047469-01-000179 | Feb 7, 2001 | — |
| SC 13G | STATEMENT OF BENEFICIAL OWNERSHIP | 0000914121-99-000887 | Oct 1, 1999 | — |
| SC 13G | — | 0000017283-99-000317 | Feb 11, 1999 | — |
| SC 13G | FORM SC 13G | 0000950116-98-001817 | Sep 1, 1998 | — |
| SC 13G | — | 0000017283-98-000304 | Jul 9, 1998 | — |
| SC 13G | — | 0000732812-98-000894 | Jul 9, 1998 | — |
| SC 13G | — | 0000017283-98-000038 | Jul 9, 1998 | — |
| SC 13G | — | 0000732812-98-000224 | Feb 11, 1998 | — |